Chemical Synthesis Facility

The Eunice Kennedy Shriver National Institute of Child Health and Human Development seeks capability statements for a Chemical Synthesis Facility capable of synthesizing potential anti-fertility agents on scales from milligrams to kilograms under current Good Manufacturing Practices. The agency intends to award a cost reimbursement contract with a one year base period and six one-year options to synthesize chemical intermediates and agents for contraceptive evaluation, including toxicology and preclinical safety studies. Capability statements are requested from small businesses with experience in rapid lab-scale synthesis, cGMP production of up to 10 kilograms, stable isotope and radiolabeled synthesis, and peptide production. Responses are due by March 21, 2022 and should not exceed 15 pages excluding resumes.

There is no set-aside designation. The anticipated NAICS code is 541712 for research and development in the physical, engineering, and life sciences with a small business size standard of 1,000 employees. The main PSC code will likely be R425 for pharmaceutical preparations. The contract has a one year base period and six one-year options with the objective of synthesizing chemical intermediates and agents for contraceptive evaluation over multiple years.